A20 cells, also called ATCC TIB-208, is a cell line originally derived from B-cell lymphoma in an old BALB/c mouse. [1] AT20 cells are BALB/c lymphoma cells derived from spontaneous reticulum cell neoplasm. [2] ATCC TIB-208 cells originated from B-cell lymphoma in the reticulum cell sarcoma of an elderly BALB/c mouse. [3] A20 cells are used in medical research such as drug screening or vaccine target selection. [4] [5] [6] A20 cells are also highly responsive to immunomodulatory antibodies, and are therefore used frequently in immunotherapy drug studies. [3]
A20 cells, also called ATCC TIB-208, is a cell line originally derived from B-cell lymphoma in an old BALB/c mouse. [1] AT20 cells are BALB/c lymphoma cells derived from spontaneous reticulum cell neoplasm. [2] ATCC TIB-208 cells originated from B-cell lymphoma in the reticulum cell sarcoma of an elderly BALB/c mouse. [3] A20 cells are used in medical research such as drug screening or vaccine target selection. [4] [5] [6] A20 cells are also highly responsive to immunomodulatory antibodies, and are therefore used frequently in immunotherapy drug studies. [3]